IMUX

Immunic, Inc. - Common Stock (IMUX)

About Immunic, Inc. - Common Stock (IMUX)

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis. The firm’s products include IMU-838, IMU-935, and IMU-856. The company was founded in May 2003 and is headquartered in New York, NY.

Details

Daily high

$8.06

Daily low

$7.21

Price at open

$7.97

52 Week High

$17.43

52 Week Low

$5.06

Market cap

108.3M

Dividend yield

Volume

156,195

Avg. volume

347,554

P/E ratio

-1.65

Immunic, Inc. - Common Stock News